NewsFeed
Headlines ASRM ESHRE FIGO ACOG Fertility and Sterility PCOS
March, 2026
March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Elizabeth Schneider: Revolutionary Drug Shows Promise for Primary Ovarian Insufficiency
Elizabeth Schneider/LinkedIn
Feb 8, 2026, 11:10

Elizabeth Schneider: Revolutionary Drug Shows Promise for Primary Ovarian Insufficiency

Elizabeth Schneider, Staff Product Marketing Manager at Illumina, shared a post on LinkedIn:

“Primary ovarian insufficiency (POI), in which the ovaries don’t mature and release eggs properly, affects about 3% of women under age 40 and typically causes infertility. But a drug already approved to treat kidney disease may one day help some of these people get pregnant, a research team reports today in Science.

In studies of mouse ovarian tissue and live mice, the drug, called finerenone, kick-started the growth of tiny egg-containing sacs, or follicles—a process that’s often defunct in people with POI. In a small clinical trial, people with POI who were given the drug went on to produce mature eggs that could be harvested, and some of the eggs were then successfully fertilized in the lab.”

Read more.

Stay updated on all scientific advances in the field of fertility with Fertility News.

Clinical Trials Drug Efficacy Drug Repurposing Elizabeth Schneider Fertility Fertility News fertility research Finerenone Research Follicle Development Hormonal Regulation infertility infertility treatment Mouse Models ovarian function Ovarian Health Ovarian insufficiency POI pregnant primary ovarian insufficiency reproductive health Reproductive Medicine Women’s Health
NewsFeed